The US Food and Drug Administration (FDA) has granted clearance to medical technology company Hologic’s new deep learning-based software, Genius AI Detection technology, for breast cancer.

The technology is designed to support radiologists in detecting subtle potential cancers in breast tomosynthesis images.

The company also announced that the Genius AI Detection is now commercially available.

According to studies, Genius AI Detection software, when used along with the Genius 3D Mammography exam, facilitates identification and early detection of breast cancer.

It works by highlighting areas with subtle potential cancers that can be difficult for the radiologist to detect for further examination.

In addition, it can provide higher sensitivity and lower false-positive rate compared to Hologic’s older generation CAD products.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Hologic Breast and Skeletal Health Solutions division president Jennifer Meade said: “Not only did studies show that Genius AI Detection aids in image interpretation by highlighting suspicious and often subtle areas of interest, it also provides the radiologist with an opportunity to prioritise the most concerning patient cases.

“This is a real game-changer as it has the potential to shorten the cycle between screening and diagnostic follow-up, and ultimately, improve patient outcomes.”

The software delivers key metrics during image acquisition, supporting radiologists in categorising and prioritising cases by complexity and expected read time to improve workflow and accelerate patient care.

Genius AI Detection is the first product available in the market that runs on the acquisition workstation of the mammography system without requiring a separate server to offer a simple, convenient, and secure environment.

It is the only 3D CAD solution that supports Hologic’s recent innovations in tomosynthesis imaging, Clarity HD, 3DQuorum imaging technology, and standard-resolution tomosynthesis.